Changes in Relevant for UDS 2026
Last updated May 13, 2026
We are currently reviewing the Program Assistance Letter and planning changes to the UDS module.
Timeline of updates
- Afternoon of April 20, 2026. we will enable the UDS 2026 measures for all health centers.
- April–May 2026. We will refresh the CQM Value Sets and RxNorm Value Set.
- Spring 2026 onward. We will incrementally update the UDS module logic.
Table 6A: Selected Services Rendered
Line Removals
May 2026. We removed Table 6A Selected Services lines that are no longer required per the 2026 Program Assistance Letter:
| Line | Service |
|---|---|
| 21c | Novel coronavirus (SARS-CoV-2) diagnostic test |
| 21d | Novel coronavirus (SARS-CoV-2) antibody test |
| 22 | Mammogram |
| 23 | Pap test |
| 30 | Sealants |
| 33 | Oral surgery |
| 34 | Rehabilitative services |
Line Revisions
May 2026. Line 26, Health supervision of infant or child (ages 0 through 11), was renamed to Well Child Visits (ages 0 through 11). We also updated Relevant to count this line using the Well Child Interventions Data Element instead of Visit Billing or Diagnosis Codes for patients under age 12 at the start of the intervention. The data element itself does not require a linked visit, but the patient must still qualify for UDS reporting in the reporting year to be included in Table 6A.
Table 6A: Selected Diagnoses
Line Additions
May 2026. We added support for the new Table 6A Selected Diagnoses line 9a. Diabetes mellitus type 1, which counts patients and visits with ICD-10 diagnosis codes in the E10* range.
Line Removals
May 2026. We removed Table 6A Selected Diagnoses lines that are no longer required per the 2026 Program Assistance Letter:
| Line | Diagnosis |
|---|---|
| 4c | Novel coronavirus (SARS-CoV-2) disease |
| 4d | Long COVID |
| 6a | Respiratory conditions related to COVID-19 |
| 7 | Abnormal breast cancer findings, female |
| 8 | Abnormal cervical findings |
| 12 | Contact dermatitis and other eczema |